ES544389A0 - Un metodo para diagnosticar una condicion neoplastica en un hospedante mamifero - Google Patents

Un metodo para diagnosticar una condicion neoplastica en un hospedante mamifero

Info

Publication number
ES544389A0
ES544389A0 ES544389A ES544389A ES544389A0 ES 544389 A0 ES544389 A0 ES 544389A0 ES 544389 A ES544389 A ES 544389A ES 544389 A ES544389 A ES 544389A ES 544389 A0 ES544389 A0 ES 544389A0
Authority
ES
Spain
Prior art keywords
diagnosing
mammal
staff
neoplastic condition
neoplastic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES544389A
Other languages
English (en)
Other versions
ES8609731A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of ES8609731A1 publication Critical patent/ES8609731A1/es
Publication of ES544389A0 publication Critical patent/ES544389A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES85544389A 1984-06-21 1985-06-20 Un metodo para diagnosticar una condicion neoplastica en un hospedante mamifero Expired ES8609731A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,309 US4752569A (en) 1984-06-21 1984-06-21 Sialylated Lewisx epitope, antibodies and diagnosis

Publications (2)

Publication Number Publication Date
ES8609731A1 ES8609731A1 (es) 1986-07-16
ES544389A0 true ES544389A0 (es) 1986-07-16

Family

ID=24497577

Family Applications (1)

Application Number Title Priority Date Filing Date
ES85544389A Expired ES8609731A1 (es) 1984-06-21 1985-06-20 Un metodo para diagnosticar una condicion neoplastica en un hospedante mamifero

Country Status (5)

Country Link
US (1) US4752569A (es)
EP (1) EP0165811A2 (es)
JP (2) JPH0630618B2 (es)
CA (1) CA1277614C (es)
ES (1) ES8609731A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873188A (en) * 1985-05-28 1989-10-10 Oncogen Method, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodies
EP0248147A3 (en) * 1986-03-04 1989-02-15 Sloan-Kettering Institute For Cancer Research Method of determining the presence of cancer cells
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
AU613590B2 (en) * 1986-11-19 1991-08-08 Bristol-Myers Squibb Company Hybridomas producing monoclonal antibodies to new mucin epitopes
EP0272792B1 (en) * 1986-11-21 1994-09-14 Imre Corporation Antigen-specific removal of circulating immune complexes
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
JPS63159763A (ja) * 1986-12-24 1988-07-02 Fujirebio Inc 逆受身凝集反応試薬
EP0287916A1 (en) * 1987-04-13 1988-10-26 Otsuka Pharmaceutical Co., Ltd. Immunoassay
US5403717A (en) * 1987-08-11 1995-04-04 Pacific Northwest Research Diagnosis of premalignant or malignant conditions of human secretory epithelia
AU2489888A (en) * 1987-09-08 1989-04-17 Biomembrane Institute, The Detection of survived, undegraded carbohydrate epitopes as diagnostic of intestinal diseases
US5206086A (en) * 1987-10-13 1993-04-27 University Of Rochester Particle-stabilized epitopes for standardization and control of immunoassays
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
US5075218A (en) * 1987-12-29 1991-12-24 Biomira, Inc. Screening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereof
EP0380084A3 (en) * 1989-01-27 1991-03-13 The Biomembrane Institute Method for the inhibition of cell-cell and cell substratum interactions by the blocking of carbohydrate-carbohydrate interactions
US5272263A (en) 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US6307025B1 (en) 1989-04-28 2001-10-23 Biogen, Inc. VCAM fusion proteins and DNA coding therefor
US5217870A (en) * 1989-04-28 1993-06-08 Biogen, Inc. Monoclonal antibodies against CDX
DK0714912T3 (da) * 1990-07-17 2003-02-03 Univ Oklahoma Funktionelt aktive selektin-deriverede peptider og ligander for GMP-140
JPH06504619A (ja) * 1990-11-23 1994-05-26 ザ ジェネラル ホスピタル コーポレーション 細胞接着蛋白質−糖質相互作用の阻害
WO1993000588A1 (en) * 1991-06-26 1993-01-07 The Biomembrane Institute Early diagnosis of lung cancer using anti-carbohydrate antibody combinations
SE9102074D0 (sv) * 1991-07-03 1991-07-03 Kabi Pharmacia Ab Tomour antigen specific antibody
WO1994007138A1 (en) * 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
US5976540A (en) * 1993-05-17 1999-11-02 T Cell Sciences, Inc. Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
WO1994026786A1 (en) 1993-05-17 1994-11-24 T Cell Sciences, Inc. Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
US5856300A (en) * 1994-05-12 1999-01-05 T Cell Sciences, Inc. Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
NO180658C (no) 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
NO961031D0 (no) 1996-03-13 1996-03-13 Det Norske Radiumshospital Tum Fremgangsmåte til å drepe uönskede målceller
US6924359B1 (en) 1999-07-01 2005-08-02 Yale University Neovascular-targeted immunoconjugates
EP1487343B1 (en) * 2002-03-05 2008-12-31 Board of Regents, The University of Texas System Biospecific contrast agents
JP5679217B2 (ja) * 2009-10-13 2015-03-04 日東紡績株式会社 Ｔ細胞非依存性抗原に対するＩｇＧ型抗体の製造方法、Ｔ細胞非依存性抗原に対するＩｇＧ型抗体を産生する遺伝子組換えカイコおよびその製造方法
US10307471B2 (en) 2013-05-02 2019-06-04 National Institute Of Advanced Industrial Science And Technology Immunity inducer for saccharide antigens

Also Published As

Publication number Publication date
JPH1052269A (ja) 1998-02-24
JPH0630618B2 (ja) 1994-04-27
JP2950792B2 (ja) 1999-09-20
ES8609731A1 (es) 1986-07-16
JPS6163700A (ja) 1986-04-01
US4752569A (en) 1988-06-21
CA1277614C (en) 1990-12-11
EP0165811A2 (en) 1985-12-27

Similar Documents

Publication Publication Date Title
ES544389A0 (es) Un metodo para diagnosticar una condicion neoplastica en un hospedante mamifero
ES534591A0 (es) Un procedimiento para fabricar microcapsulas
NO164932C (no) Kjernegriper for anvendelse i et kjerneopptakerverktoey.
ES489346A0 (es) Mejoras en un procedimiento para producir microcapsulas
ES536680A0 (es) Un metodo para detectar una interaccion ligante
ES543192A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES504447A0 (es) Perfeccionamientos en un alabe para turbomaquina
MX163014B (es) Mejoras en un ensamble soportador para una flecha rotatoria
ES534694A0 (es) Un procedimiento para preparar cefuroxima sodica
ES534752A0 (es) Un procedimiento para preparar una adenosina sustituida en n6
ES536152A0 (es) Un procedimiento para producir l-arginina
ES543929A0 (es) Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato
ES547004A0 (es) Un procedimiento para preparar hidantoinas opticamente acti-vas
ES544838A0 (es) Perfeccionamientos en un dispositivo para elevar sujetadores
ES546157A0 (es) Un procedimiento para preparar quinolonas
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES534170A0 (es) Un procedimiento para preparar 1-piridil-alquil-4-aril-piperazinas
ES544864A0 (es) Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona
ES557018A0 (es) Un metodo para elaborar una cinta basada en politetrafluoroetileno
ES545834A0 (es) Un procedimiento para preparar una quinolona
BR8507327A (pt) Poliesteres mistos soluveis em agua,processo para a sua obtencao e sua utilizacao
AR240937A1 (es) Procedimiento para preparar una benzoquinolicina
ES535847A0 (es) Un procedimiento para producir un uroquinasa-zimogeno
BR8401666A (pt) Filamentos conjugados e processos para a sua producao
ES548727A0 (es) Un procedimiento para producir una linfocina (lk 2)